Arjo Products
VTE prevention solutions
VTE is a serious condition that causes death and disability worldwide, with 10 million cases each year.
In order to safeguard the well-being of at-risk patients, comprehensive venous thromboembolism prevention strategies that take into account individual clinical needs are essential.
Meet Stefan Elvenes, former ice hockey player and VTE patient
Stefan was diagnosed with a blood clot shortly after retiring. At 37 years old, fit and healhty, it was a complete shock to be faced with this life threatening condition.
Book a training session
We provide full training for all our equipment. To find out just how easy the Flowtron ACS900 is to use, book a training session today.
Flowtron ACS900 is proven to make a difference
Feedback from 188 users at 32 hospitals in Australia, France, the UK, and USA concludes that the Flowtron ACS900 and Tri Pulse system make a positive difference for VTE prevention therapy.
Experience the Flowtron ACS900
Book a demo now and experience first-hand how the Flowtron ACS900 can cover all your intermittent pneumatic compression (IPC) therapy needs.
What patients need to know about VTE prevention
Help patients understand the risks of VTE, the role of prevention during their hospital stay, and what to be aware of after leaving the hospital with this patient leaflet.
Safe, convenient and flexible VTE Prevention Solution
VTE is a serious condition that causes death and disability worldwide, with 10 million cases each year.
In order to safeguard the well-being of at-risk patients, comprehensive venous thromboembolism prevention strategies that take into account individual clinical needs are essential.
The burden of VTE
Critical care, cancer, obstetrics, bariatric, stroke patients, and those subject to 30+ minutes surgical procedures in general, are all at risk of VTE. You can download our brochure here.
Key clinical evidence supporting the use of IPC
We invite you to review this clinical resource providing examples of some of the key evidence supporting the use of IPC and specifically the Flowtron Active Compression System as part of a VTE prevention programme. You can download our clinical evidence brochure.
VTE ACS900 Compliance Monitoring
Flowtron ACS900 Compliance Monitoring will help to ensure effective delivery of IPC therapy and support clinical outcomes.
Related content for our VTE prevention category
Understanding the Importance of Compression Therapy in VTE Prevention
When we get a small wound, we often praise our blood’s ability to clot to protect the wound and prevent further blood loss. However, when blood starts to clot in the wrong place at the wrong time, the consequences can be life-changing, even fatal. Every year, blood clots in the deep veins cause...
Including VTE prevention solutions in surgical procedures to positively impact patients’ health and wellbeing
While healthcare facilities are aware of the risk of venous thromboembolism (VTE), care providers do not always have the time, training or resources to implement optimal prevention strategies. Learn how a clinic in Scandinavia has succeeded in integrating VTE prevention solutions in their surgery...
Five key benefits of our upgraded VTE prevention solution Flowtron® Active Compression system
Providing a solution for the largest preventable cause of hospital deaths, venous thromboembolism (VTE) prevention is an important and growing area within Arjo. Our upgraded and improved solution, the Flowtron Active Compression System, is now launched – and here are the key benefits.
How is mechanical prophylaxis used in VTE Prevention?
Venous Thromboembolism (VTE) is a leading cause of death and disability worldwide but research suggests that it can be preventable through evidence-based prevention strategies. Learn more about mechanical prophylaxis and Intermittent Pneumatic Compression (IPC) with our downloadable summary below.
Untangling the Tangled Haemostatic Web: The Essence of VTE Risk Assessment and Evidence
Arjo, together with Dr. Joseph A. Caprini - Senior Clinician Educator at the Pritzker School of Medicine at the University of Chicago invites you to this educational webinar. The focus of this lecture is the approach to the prevention of the number one preventable cause of death after surgery or...
